Literature DB >> 4399501

Evidence for a centrally mediated hypotensive effect of L-dopa in the rat.

M Henning, A Rubenson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4399501     DOI: 10.1111/j.2042-7158.1970.tb08510.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  16 in total

1.  Central tyramine prevents hypertension in uninephrectomized DOCA-saline treated rats.

Authors:  B Shalita; S Dikstein
Journal:  Experientia       Date:  1977-11-15

2.  Sympathetic vasoconstrictor reflexes in Parkinson's disease with autonomic dysfunction.

Authors:  E B Andersen; F Boesen
Journal:  Clin Auton Res       Date:  1997-02       Impact factor: 4.435

3.  The cardiovascular effects of bromocriptine in Parkinsonism.

Authors:  J K Greenacre; P F Teychenne; A Petrie; D B Calne; P N Leigh; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

4.  Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.

Authors:  J R Fozard; M G Palfreyman; M Robin; M Zreika
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

Review 5.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

6.  Cardiovascular effects of 6-hydroxydopamine injected into a lateral brain ventricle of the rat.

Authors:  G Haeusler; M Gerold; H Thoenen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  An analysis of the peripheral effects of l-DOPA on autonomic nerve function.

Authors:  M J Antonaccio; R D Robson
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739

8.  Genetically hypertensive rats: relationship between the development of hypertension and the changes in norepinephrine turnover of peripheral and central adrenergic neurons.

Authors:  K Nakamura; M Gerold; H Thoenen
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

9.  Blood pressure responses to noradrenaline and dopamine infusions in Parkinson's disease and the Shy-Drager syndrome.

Authors:  C S Wilcox; M J Aminoff
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

10.  Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.

Authors:  L Finch; G Haeusler
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.